Institution
Orlando Health
- 66running trials
- 20closed trials
- 3,180publications (OpenAlex)
Running trials
Recruiting
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Enrolling by invitation
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Recruiting
Active, not recruiting
Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Recruiting
Recruiting
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Recruiting
Recruiting
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Recruiting
Recruiting
Active, not recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
Recruiting
Recruiting
Recruiting
Recruiting
EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
Active, not recruiting
Recruiting
Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Active, not recruiting
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Active, not recruiting
Active, not recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
Active, not recruiting
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 66.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease4 recruiting
- Obesity4 recruiting
- Ulcerative colitis3 recruiting
- Atrial fibrillation2 recruiting
- COPD2 recruiting
- Endometrial cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Pancreatic cancer2 recruiting
- Type 2 diabetes2 recruiting
- Asthma1 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Coeliac disease1 recruiting
- Colorectal cancer1 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Irritable bowel syndrome1 recruiting
- Meningioma1 recruiting
- Ovarian cancer1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
Completed
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Terminated
Terminated
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
Completed
Completed
Terminated
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Completed
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Completed
Terminated
Completed
The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Completed
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Completed
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Completed
Registry name variants (12)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Orlando Health
Orlando, Florida 32806
56 trials
Orlando Health, Inc.
Orlando, Florida 32806
17 trials
Orlando Health, Inc.- APH Center for Digestive Health and Nutrition
Orlando, Florida 32806
3 trials
Orlando Health, Inc.-Site Number: 8400084
Orlando, Florida 32806
2 trials
Orlando Health - 1130
Orlando, Florida 32806
1 trial
Orlando Health, Inc. d/b/a Orlando Health UF Health Center
Orlando, Florida 32806
1 trial
Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084
Orlando, Florida 32806
1 trial
Orlando Health, Inc. (Site 0035)
Orlando, Florida 32806
1 trial
Orlando Health, Inc. (Site 0216)
Orlando, Florida 32806
1 trial
Orlando Health (Site 0145)
Orlando, Florida 32806
1 trial
Orlando Health, UF Health Cancer Center Inc (Site 0092)
Orlando, Florida 32806
1 trial
University of Florida (UF) Health Cancer Center - Orlando Health
Orlando, Florida 32806
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Haemophagocytic lymphohistiocytosis3 works · 0 trials
Institution data: ROR 0488cct49 (CC0-1.0)Updated 15 Nov 2026